Lakewood-Amedex Biotherapeutics Inc.

Lakewood-Amedex Biotherapeutics Announces Completion of Series C Convertible Preferred Stock Redemption

Lakewood-Amedex Biotherapeutics Inc. (NASDAQ: LABT) (the "Company"), a clinical-stage biotechnology company advancing a novel class of potent,…